Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Marius Pharmaceuticals LLC

Marius Pharmaceuticals Welcomes John "Shrek" Mcphee as Kyzatrex® (testosterone undecanoate) CIII Capsules Patient Ambassador
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Partners with Major Academic Medical Center on Education and Research Efforts for Oral Testosterone
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Helps Drive FDA’s Landmark Testosterone Label Update, Removing Black Box Warning
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisory Boards
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
From Marius Pharmaceuticals LLC
Via GlobeNewswire
KYZATREX® (testosterone undecanoate) CIII Capsules EXPANDS DISTRIBUTION THROUGH NEW COLLABORATION WITH GAMEDAY MEN’S HEALTH
From Marius Pharmaceuticals LLC
Via GlobeNewswire
The Testosterone Project Launches on National Testosterone Awareness Day, November 17
From Marius Pharmaceuticals LLC
Via GlobeNewswire
New Data from Marius Pharmaceuticals Reveals High Prevalence of Low Libido, Energy and Quality of Life in Men
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Partners with UK-Based Numan to Combat Testosterone Deficiency with KYZATREX® (Testosterone Undecanoate) CIII Capsules
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Partners with Smartway to Design and Manage the global Early Access Program for KYZATREX™ (testosterone undecanoate)
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
From Marius Pharmaceuticals LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.